Autopsy report · NCT02147834

Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents

“due to futility”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months before it started.
• Ran for about 1 year 1 month before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 2 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

North Florida Foundation for Research and Education

Sponsor type

University, hospital or other

Conditions

Angina

Interventions

Ranolazine; Sugar pill

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
  “Futility” (78% match in meaning)
• Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
  “for futility” (76% match in meaning)
• Prevention of Unexplained Recurrent Abortion by Enoxaparine
  “Stopped for futility” (67% match in meaning)
• The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
  “futility ground” (61% match in meaning)
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
  “Due to business reasons” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.